Drug Profile
Research programme: oncofetal antigen peptides - Quantum Immunologics
Alternative Names: OFA/iLRP peptidesLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator University of South Alabama
- Developer Quantum Immunologics
- Class Peptides
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA (Parenteral)
- 08 Nov 2010 Preclinical trials in Cancer in USA (Parenteral)